Difluoromethylornithine: the proof is in the polyamines.
Cancer Prev Res (Phila)., Dec;5(12):1341-4 (2012)
Health Care Expenditures, Hospitalizations, and Productivity Associated With Cancer in US Employer Settings.
J. Occup. Environ. Med., Dec;54(12):1453-60 (2012)
Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention.
Cancer Prev Res (Phila)., Dec;5(12):1381-93 (2012)
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.
Gynecol. Oncol., Dec;127(3):451-5 (2012)
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity.
Cancer., Dec;118(23):5848-56 (2012)
Loss of heterozygosity at the glutathione peroxidase 1 locus is not an early event in colon carcinogenesis.
Genes Cancer., Sep;2(9):910-3 (2011)
Karyometry of nuclear phenotypes in cutaneous squamous cell cancer.
Anal. Quant. Cytol. Histol., Feb;34(1):1-8 (2012)
Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer.
Invest New Drugs., May (2012)
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.
Clin. Cancer Res., May;18(9):2668-78 (2012)
Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.
Cancer Prev Res (Phila)., Mar;5(3):403-13 (2012)
Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Gynecol. Oncol., Apr;125(1):129-35 (2012)
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
Cancer Prev Res (Phila)., Feb;5(2):197-204 (2012)
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Cancer Prev Res (Phila)., Nov;4(11):1761-9 (2011)
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometryâ˜†
Urol. Oncol., Jul (2011)
Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
Clin Colorectal Cancer., Dec;10(4):310-6 (2011)
Nuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.
Cancer Prev Res (Phila)., Nov;4(11):1770-7 (2011)
p38 MAP kinase plays a functional role in UVB-induced mouse skin carcinogenesis.
Mol. Carcinog., Jun;50(6):469-78 (2011)
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer.
J Support Oncol., 8(6):252-8 (2010 Nov-Dec)
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009.
Int. J. Gynecol. Cancer., Oct;20(7):1290-8 (2010)
Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.
Nutr Cancer., 62(8):1058-66 (2010)